Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer

Richard K Valicenti, John W. Sweet, Walter W. Hauck, Richard S. Hudes, Tony Lee, Adam P. Dicker, Frank M. Waterman, Pramila R. Anne, Benjamin W. Corn, James M. Galvin

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Purpose: Currently, three-dimensional conformal radiation therapy (3D- CRT) planning relies on the interpretation of computed tomography (CT) axial images for defining the clinical target volume (CTV). This study investigates the variation among multiple observers to define the CTV used in 3D-CRT for prostate cancer. Methods and Materials: Seven observers independently delineated the CTVs (prostate ± seminal vesicles [SV]) from the CT simulation data of 10 prostate cancer patients undergoing 3D-CRT. Six patients underwent CT simulation without the use of contrast material and serve as a control group. The other 4 had urethral and bladder opacification with contrast medium. To determine interobserver variation, we evaluated the derived volume, the maximum dimensions, and the isocenter for each examination of CTV. We assessed the reliability in the CTVs among the observers by correlating the variation for each class of measurements. This was estimated by intraclass correlation coefficient (ICC), with 1.00 defining absolute correlation. Results: For the prostate volumes, the ICC was 0.80 (95% confidence interval [CI]: 0.56-0.96). This changed to 0.92 (95% CI: 0.75-0.99) with the use of contrast material. Similarly, the maximal prostatic dimensions were reliable and improved. There was poor agreement in defining the SV. For this structure, the ICC never exceeded 0.28. The reliability of the isocenter was excellent, with the ICC exceeding 0.83 and 0.90 for the prostate ± SV, respectively. Conclusions: In 3D-CRT for prostate cancer, there was excellent agreement among multiple observers to define the prostate target volume but poor agreement to define the SV. The use of urethral and bladder contrast improved the reliability of localizing the prostate. For all CTVs, the isocenter was very reliable and should be used to compare the variation in 3D dosimetry among multiple observers.

Original languageEnglish (US)
Pages (from-to)931-935
Number of pages5
JournalInternational Journal of Radiation Oncology Biology Physics
Volume44
Issue number4
DOIs
StatePublished - Jul 1 1999
Externally publishedYes

Fingerprint

Seminal Vesicles
Prostate
radiation therapy
Prostatic Neoplasms
Radiotherapy
cancer
correlation coefficients
Contrast Media
Observer Variation
Tomography
bladder
tomography
Urinary Bladder
confidence
Confidence Intervals
intervals
data simulation
dosimeters
planning
examination

Keywords

  • Clinical target volume
  • Prostate cancer
  • Radiation therapy
  • Variation

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. / Valicenti, Richard K; Sweet, John W.; Hauck, Walter W.; Hudes, Richard S.; Lee, Tony; Dicker, Adam P.; Waterman, Frank M.; Anne, Pramila R.; Corn, Benjamin W.; Galvin, James M.

In: International Journal of Radiation Oncology Biology Physics, Vol. 44, No. 4, 01.07.1999, p. 931-935.

Research output: Contribution to journalArticle

Valicenti, Richard K ; Sweet, John W. ; Hauck, Walter W. ; Hudes, Richard S. ; Lee, Tony ; Dicker, Adam P. ; Waterman, Frank M. ; Anne, Pramila R. ; Corn, Benjamin W. ; Galvin, James M. / Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. In: International Journal of Radiation Oncology Biology Physics. 1999 ; Vol. 44, No. 4. pp. 931-935.
@article{aa95bff7cbd7444fa8ae741461fa6e00,
title = "Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer",
abstract = "Purpose: Currently, three-dimensional conformal radiation therapy (3D- CRT) planning relies on the interpretation of computed tomography (CT) axial images for defining the clinical target volume (CTV). This study investigates the variation among multiple observers to define the CTV used in 3D-CRT for prostate cancer. Methods and Materials: Seven observers independently delineated the CTVs (prostate ± seminal vesicles [SV]) from the CT simulation data of 10 prostate cancer patients undergoing 3D-CRT. Six patients underwent CT simulation without the use of contrast material and serve as a control group. The other 4 had urethral and bladder opacification with contrast medium. To determine interobserver variation, we evaluated the derived volume, the maximum dimensions, and the isocenter for each examination of CTV. We assessed the reliability in the CTVs among the observers by correlating the variation for each class of measurements. This was estimated by intraclass correlation coefficient (ICC), with 1.00 defining absolute correlation. Results: For the prostate volumes, the ICC was 0.80 (95{\%} confidence interval [CI]: 0.56-0.96). This changed to 0.92 (95{\%} CI: 0.75-0.99) with the use of contrast material. Similarly, the maximal prostatic dimensions were reliable and improved. There was poor agreement in defining the SV. For this structure, the ICC never exceeded 0.28. The reliability of the isocenter was excellent, with the ICC exceeding 0.83 and 0.90 for the prostate ± SV, respectively. Conclusions: In 3D-CRT for prostate cancer, there was excellent agreement among multiple observers to define the prostate target volume but poor agreement to define the SV. The use of urethral and bladder contrast improved the reliability of localizing the prostate. For all CTVs, the isocenter was very reliable and should be used to compare the variation in 3D dosimetry among multiple observers.",
keywords = "Clinical target volume, Prostate cancer, Radiation therapy, Variation",
author = "Valicenti, {Richard K} and Sweet, {John W.} and Hauck, {Walter W.} and Hudes, {Richard S.} and Tony Lee and Dicker, {Adam P.} and Waterman, {Frank M.} and Anne, {Pramila R.} and Corn, {Benjamin W.} and Galvin, {James M.}",
year = "1999",
month = "7",
day = "1",
doi = "10.1016/S0360-3016(99)00090-5",
language = "English (US)",
volume = "44",
pages = "931--935",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer

AU - Valicenti, Richard K

AU - Sweet, John W.

AU - Hauck, Walter W.

AU - Hudes, Richard S.

AU - Lee, Tony

AU - Dicker, Adam P.

AU - Waterman, Frank M.

AU - Anne, Pramila R.

AU - Corn, Benjamin W.

AU - Galvin, James M.

PY - 1999/7/1

Y1 - 1999/7/1

N2 - Purpose: Currently, three-dimensional conformal radiation therapy (3D- CRT) planning relies on the interpretation of computed tomography (CT) axial images for defining the clinical target volume (CTV). This study investigates the variation among multiple observers to define the CTV used in 3D-CRT for prostate cancer. Methods and Materials: Seven observers independently delineated the CTVs (prostate ± seminal vesicles [SV]) from the CT simulation data of 10 prostate cancer patients undergoing 3D-CRT. Six patients underwent CT simulation without the use of contrast material and serve as a control group. The other 4 had urethral and bladder opacification with contrast medium. To determine interobserver variation, we evaluated the derived volume, the maximum dimensions, and the isocenter for each examination of CTV. We assessed the reliability in the CTVs among the observers by correlating the variation for each class of measurements. This was estimated by intraclass correlation coefficient (ICC), with 1.00 defining absolute correlation. Results: For the prostate volumes, the ICC was 0.80 (95% confidence interval [CI]: 0.56-0.96). This changed to 0.92 (95% CI: 0.75-0.99) with the use of contrast material. Similarly, the maximal prostatic dimensions were reliable and improved. There was poor agreement in defining the SV. For this structure, the ICC never exceeded 0.28. The reliability of the isocenter was excellent, with the ICC exceeding 0.83 and 0.90 for the prostate ± SV, respectively. Conclusions: In 3D-CRT for prostate cancer, there was excellent agreement among multiple observers to define the prostate target volume but poor agreement to define the SV. The use of urethral and bladder contrast improved the reliability of localizing the prostate. For all CTVs, the isocenter was very reliable and should be used to compare the variation in 3D dosimetry among multiple observers.

AB - Purpose: Currently, three-dimensional conformal radiation therapy (3D- CRT) planning relies on the interpretation of computed tomography (CT) axial images for defining the clinical target volume (CTV). This study investigates the variation among multiple observers to define the CTV used in 3D-CRT for prostate cancer. Methods and Materials: Seven observers independently delineated the CTVs (prostate ± seminal vesicles [SV]) from the CT simulation data of 10 prostate cancer patients undergoing 3D-CRT. Six patients underwent CT simulation without the use of contrast material and serve as a control group. The other 4 had urethral and bladder opacification with contrast medium. To determine interobserver variation, we evaluated the derived volume, the maximum dimensions, and the isocenter for each examination of CTV. We assessed the reliability in the CTVs among the observers by correlating the variation for each class of measurements. This was estimated by intraclass correlation coefficient (ICC), with 1.00 defining absolute correlation. Results: For the prostate volumes, the ICC was 0.80 (95% confidence interval [CI]: 0.56-0.96). This changed to 0.92 (95% CI: 0.75-0.99) with the use of contrast material. Similarly, the maximal prostatic dimensions were reliable and improved. There was poor agreement in defining the SV. For this structure, the ICC never exceeded 0.28. The reliability of the isocenter was excellent, with the ICC exceeding 0.83 and 0.90 for the prostate ± SV, respectively. Conclusions: In 3D-CRT for prostate cancer, there was excellent agreement among multiple observers to define the prostate target volume but poor agreement to define the SV. The use of urethral and bladder contrast improved the reliability of localizing the prostate. For all CTVs, the isocenter was very reliable and should be used to compare the variation in 3D dosimetry among multiple observers.

KW - Clinical target volume

KW - Prostate cancer

KW - Radiation therapy

KW - Variation

UR - http://www.scopus.com/inward/record.url?scp=0033026886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033026886&partnerID=8YFLogxK

U2 - 10.1016/S0360-3016(99)00090-5

DO - 10.1016/S0360-3016(99)00090-5

M3 - Article

VL - 44

SP - 931

EP - 935

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 4

ER -